-+ 0.00%
-+ 0.00%
-+ 0.00%

Everest Medicines Holds Extraordinary General Meeting

PUBT·11/16/2026 11:47:03
Listen to the news
Everest Medicines Holds Extraordinary General Meeting
  • Everest Medicines shareholders approved the Strategic Cooperation Framework Agreement at an extraordinary general meeting on November 16, 2026.
  • Approval covered the contemplated transactions, including annual caps for the years ending December 31, 2026, 2027 and 2028.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261116-12414721), on November 16, 2026, and is solely responsible for the information contained therein.